The online version of this article (doi:10.1186/1475-2875-11-299) contains supplementary material, which is available to authorized users.
OS is a member of, and JC receives research support from, the Clinton Health Access Initiative, which is actively supporting efforts to expand funding for and implementation of ACT treatment in the private sector.
PY, JC, and JA were involved in the conception, design, analysis, data interpretation and writing of the manuscript. SA participated in the design, coordination of the study, analysis, and drafting of the manuscript. PL performed statistical analyses and was involved in drafting the manuscript. OS and JM provided inputs to study design, study context, and drafting of the manuscript. All authors read and approved of the final manuscript.
The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-national subsidy program that aims to increase access and affordability of artemisinin combination therapy (ACT) in public sector clinics and private retail shops. It is unclear to what extent the AMFm model will translate into wide scale availability and price reductions in ACT, particularly for rural, remote areas where disparities in access to medicines often exist. This study is the first to rigorously examine the availability and price of subsidized ACT during the first year of the AMFm, measured through retail audits in remote regions of Tanzania.
Periodic retail audits of Accredited Drug Dispensing Outlets (ADDOs) were conducted in two remote regions of Tanzania (Mtwara and Rukwa). Temporal and spatial variation in ACT availability and pricing were explored. A composite measure of ADDO remoteness, using variables, such as distance to suppliers and towns, altitude and population density, was used to explore whether ACT availability and price vary systematically with remoteness.
Between February 2011 and January 2012, the fraction of ADDOs stocking AMFm-ACT increased from 25% to 88% in Mtwara and from 3% to 62% in Rukwa. Availability was widespread, though diffusion throughout the region was achieved more quickly in Mtwara. No significant relationship was found between ACT availability and remoteness. Adult doses of AMFm-ACT were much more widely available than any other age/weight band. Average prices fell from 1529 TZS (1.03 USD) to 1272 TZS (0.81 USD) over the study period, with prices in Rukwa higher than Mtwara. The government recommended retail price for AMFm- ACT is 1,000 TZS ($0.64 USD). The median retail ACT price in the final round of data collection was 1,000 TZS.
The AMFm led to large increases in availability of low priced ACT in Tanzania, with no significant variation in availability based on remoteness. Availability did remain lower and prices remained higher in Rukwa, which is a more remote region overall. Low availability of child and adolescent ACT doses could be due in part to lower quantities of non-adult packs imported into Tanzania. Future research will explore whether increased availability and affordability persists and whether it translates into higher ACT use in Tanzania.
Additional file 1: ADDO Characteristics. Details of ADDOs. (DOCX 17 KB)12936_2012_2494_MOESM1_ESM.docx
Additional file 2: Non AMFm WHO approved ACT availability. Details on availability of Non AMFm subsidized but WHO approved ACT. (DOCX 14 KB)12936_2012_2494_MOESM2_ESM.docx
Additional file 3: Shopkeeper Reported Retail Price. Details on Shopkeeper Reported Retail Price. (DOCX 17 KB)12936_2012_2494_MOESM3_ESM.docx
Additional file 4: Tanzania AMFm orders. Description: Details on AMFM orders in Tanzania. (DOCX 18 KB)12936_2012_2494_MOESM4_ESM.docx
Authors’ original file for figure 112936_2012_2494_MOESM5_ESM.pdf
Authors’ original file for figure 212936_2012_2494_MOESM6_ESM.pdf
Authors’ original file for figure 312936_2012_2494_MOESM7_ESM.tiff
Authors’ original file for figure 412936_2012_2494_MOESM8_ESM.tiff
Authors’ original file for figure 512936_2012_2494_MOESM9_ESM.tiff
Authors’ original file for figure 612936_2012_2494_MOESM10_ESM.pdf
Authors’ original file for figure 712936_2012_2494_MOESM11_ESM.doc
Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, Munroe E, Chapman S, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi C, Agbango J, Ramarosandratana B, Coker B, Rubahika D, Hamainza B, Shewchuk T, Chavasse D, O’Connell K: Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J. 2011, 10: 327-10.1186/1475-2875-10-327. PubMedCentralCrossRefPubMed
O’Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D: Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J. 2011, 10: 326-10.1186/1475-2875-10-326. PubMedCentralCrossRefPubMed
Sabot O, Yeun S, Pagnoni F, Gordon M, Petty N, Schmits K, Talisuna A: Distribution of artemisinin-based combination therapies through private-sector channels: Lessons from four country case studies. Jan 2008 Available: http://www.rff.org/RFF/Documents/RFF-DP-08-43_FINAL.pdf Accessed 12 August 2012,
Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C: Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One. 2009, 4: e6857-10.1371/journal.pone.0006857. PubMedCentralCrossRefPubMed
Kangwana B, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, Fegan GW, Todd J, Brooker S, Snow RW, Goodman C: The impact of retail sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya-a cluster randomized controlled trial. PLoS Med. 2011, 8: e1000437-10.1371/journal.pmed.1000437. PubMedCentralCrossRefPubMed
Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, Bishop D, Odhiambo M, Ipuge Y, Ward L, Mwita A, Goodman C: A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Services Res. 2010, 10 (Suppl 1): S6-10.1186/1472-6963-10-S1-S6. CrossRef
Rutta E, Senauer K, Johnson K, Adeya G, Mbwasi R, Liana J, Kimatta S, Sigonda M, Alphonce E: Creating a new class of pharmaceutical services provider for underserved areas: the Tanzania accredited drug dispensing outlet experience. Prog in Community Health Partnersh: Res, Education, and Action. 2009, 3: 145-153. 10.1353/cpr.0.0063. CrossRef
Alba S, Hetzel MW, Goodman C, Dillip A, Jafari L, Mshinda H, Lengeler C: Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets-a provider perspective. Malar J. 2010, 9: 164-10.1186/1475-2875-9-164. PubMedCentralCrossRefPubMed
Tanzania Commission for AIDS, Zanzibar AIDS Commission, National Bureau of Statistics, Office of the Chief Government Statistician, and Macro International Inc: Tanzania HIV/AIDS and Malaria Indicator Survey 2007–08. 2008, Dar es Salaam
The Planning Commission Dar es Salaam and Regional Commissioner’s Office Mtwara: Mtwara Region Socioeconomic Profile. 1997, Dar es Salaam
The Planning Commission Dar es Salaam and Regional Commissioner’s Office Rukwa: Rukwa Region Socioeconomic Profile. 1998, Dar es Salaam, Dar es Salaam
The National Bureau of Statistics and Ministry of Finance: Tanzania in Figures 2010. 2011, Dar es Salaam
Rourke J: In search of a definition of "rural". Can J Rural Med. 1997, 2: 113-
Roberts P, Shyam KC, Rastogi C: Rural Access Index: A Key Development Indicator. Transport Paper No. TP-10, 49 pp. 2006, World Bank, Washington D.C., USA
- Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania
Jessica L Cohen
Peter S Larson
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II